fbpx

Gallant

Los Angeles, CA
www.gallant.com

Service:  Stem cell banking for dogs

Category: Pet Health
Competitors: Viagen,
Fuzzy,
Televet,
whiskerDocs

Founded: 2018
Number of Employees: 11 – 50
Estimated Annual Revenue:

Notes

Gallant is a pet biotech company that banks stem cells and also develops stem cell therapies. 

Veterinarians are able to extract stem cells when a dog is spayed or neutered.

Aaron Hirschhorn, the founder, previously started DogVacy and oversaw its merger with Rover in 2017.  In 2019, Gallant raised $11 million in funding from several investors, including Maveron.and Bold Capital Partners.

Daryl Rawlings, the founder of Trupanion pet insurance, is a member of the board.